GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Case-based discussion with multiple lung cancer experts on optimal treatment of a patient with advanced lung adenocarcinoma, EGFR mutation, & now acquired resistance to EGFR TKI after very good prior response.

Direct download: GRACEcast-088_Lung-Audio_CCILC_Acquired_Resistance.mp3
Category:Lung-Cancer-Audio -- posted at: 10:21am PDT

Case-based discussion with multiple lung cancer experts on optimal treatment of a patient with advanced lung adenocarcinoma, EGFR mutation, & now acquired resistance to EGFR TKI after very good prior response.

Direct download: GRACEcast-088_Lung-Video_CCILC_Acquired_Resistance.m4v
Category:Lung-Cancer-Video -- posted at: 10:17am PDT

Dr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, reviews technical advances in CT screening for lung nodules, features  suggesting whether a nodule is benign or malignant, and the CT-guided biopsy procedure.

Direct download: GRACEcast-087_Lung-Audio_Yankelevitz_on_Lung_Nodules.mp3
Category:Lung-Cancer-Audio -- posted at: 10:49pm PDT

Dr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, reviews technical advances in CT screening for lung nodules, features  suggesting whether a nodule is benign or malignant, and the CT-guided biopsy procedure.

Direct download: GRACEcast-087_Lung-Video_Yankelevitz_on_Lung_Nodules.m4v
Category:Lung-Cancer-Video -- posted at: 10:43pm PDT

Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-086_Lung-Video_Solomon_Camidge_ALK_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PDT

Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-086_Lung-Audio_Solomon_Camidge_ALK_QnA.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PDT

Dr. Ross Camidge reviews considerations of who to screen for an ALK rearrangement and additional treatment alternatives for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-085_Lung-Audio_Camidge_on_ALK-Positive.mp3
Category:Lung-Cancer-Audio -- posted at: 5:30pm PDT

Dr. Ross Camidge reviews considerations of who to screen for an ALK rearrangement and additional treatment alternatives for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-085_Lung-Video_Camidge_on_ALK-Positive.m4v
Category:Lung-Cancer-Video -- posted at: 5:29pm PDT

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-084_Lung-Audio_Solomon_on_ALK_Inhibition.mp3
Category:Lung-Cancer-Audio -- posted at: 11:49pm PDT

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-084_Lung-Video_Solomon_on_ALK_Inhibition.m4v
Category:Lung-Cancer-Video -- posted at: 11:48pm PDT